Lobbying Filing Details

Total Spending

$30,000

Activities

1

Lobbyists

1

Gov't Entities

1

Filing Information

Filing UUID:: 40d92688-2c21-476e-bae9-8efb4fcb0375
Type:: Q2 - 2nd Quarter - Report
Period:: 2022 - 2nd Quarter (Apr 1 - June 30)
Date Posted:: July 19, 2022 at 6:22 PM
Income:: $30,000
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: Darren Willcox

Registrant

W STRATEGIES, LLC

Government Affairs Consulting Firm.

Washington, District of Columbia

Client

STOKE THERAPEUTICS

Biotechnology company.

Massachusetts, United States of America

Lobbying Activities (1)

Activity 1

Health Issues

Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.

Lobbyists (1)

DARREN WILLCOX

Government Entities (1)

HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.